Statin treatment and the risk of recurrent pulmonary embolism.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Heart Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/eht124PMID 23585491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery.

  2013cited by this paper
• Statin treatment and the risk of recurrent pulmonary embolism.

  2013cited by this paper
• A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

  2009cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.

  2006cited by this paper
• The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes.

  2005cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.

  2004cited by this paper
• Increased Expression of Interleukin-1 in Coronary Artery Disease With Downregulatory Effects of HMG-CoA Reductase Inhibitors

  2004cited by this paper
• Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress

  2004cited by this paper
• Endothelial function: a critical determinant in atherosclerosis?

  2004cited by this paper
• Integral Role of RhoA Activation in Monocyte Adhesion–Triggered Tissue Factor Expression in Endothelial Cells

  2003cited by this paper
• Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.

  2003cited by this paper
• Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho Family

  2003cited by this paper
• Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II

  2003cited by this paper
• Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation

  2001cited by this paper
• Effect of Lipid-Lowering Treatment on Factor VII Profile in Hyperlipidemic Patients

  2000cited by this paper

• The impact of statins on pulmonary embolism severity—a retrospective data analysis

  2025cites this paper
• Clinical Outcomes Associated with Statin Use in Pulmonary Embolism: A Systematic Review of Observational Studies

  2025influential citation
• Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD

  2024cites this paper
• Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review

  2024cites this paper
• Impact of statin treatment on cardiovascular events in patients with retinal vein occlusion: a nested case-control study in Korea

  2023cites this paper
• Pulmonary embolism at CT pulmonary angiography in patients with COVID-19 at a tertiary care center in Nepal: a cross-sectional study

  2023cites this paper
• Statins Effects on Blood Clotting: A Review

  2023cites this paper
• Statin therapy in venous thromboembolism: How far from primary and secondary prevention?

  2022cites this paper
• Statin use and 30‐day mortality in patients with acute symptomatic pulmonary embolism

  2022cites this paper
• Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

  2021cites this paper
• Analysis of Clinical and Radiological Findings in Oncology Patients Undergoing Thoracic Tomography for Suspected Pulmonary Embolism

  2021influential citation
• COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection

  2021cites this paper
• Drugs and liver injury: a not to be overlooked binomial in COVID-19

  2021cites this paper
• Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study

  2021cites this paper
• Statins in COVID-19 Therapy

  2021cites this paper
• Acute Pulmonary Embolism and COVID-19

  2020cites this paper
• Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19

  2020cites this paper
• Open Respiratory Archives

  2019cites this paper
• Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies

  2018cites this paper
• Rosuvastatin use improves measures of coagulation in patients with venous thrombosis

  2018cites this paper
• Effect of simvastatin on the SIRT2/NF-κB pathway in rats with acute pulmonary embolism

  2018cites this paper
• Statins and venous thromboembolism: do they represent a viable therapeutic agent?

  2017cites this paper
• Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing

  2017cites this paper
• Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

  2017cites this paper
• Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.

  2017cites this paper
• Statins as a preventative therapy for venous thromboembolism.

  2017cites this paper
• Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

  2017cites this paper
• Optimization of monitoring and management of anticoagulant therapy

  2017cites this paper
• Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies

  2017cites this paper
• Use of statins and reduced risk of recurrence of VTE in an older population

  2016cites this paper
• The association of statin therapy with the risk of recurrent venous thrombosis

  2016cites this paper
• Venous thromboembolism has the same risk factors as atherosclerosis

  2016cites this paper
• Venous and Arterial Thrombosis: Is There a Link?

  2016cites this paper
• Long Term Clinical Course of Hemodynamic Stable Pulmonary Embolism

  2016cites this paper
• Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism.

  2016cites this paper
• Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).

  2015cites this paper
• Epidemiology of venous thromboembolism

  2015cites this paper
• Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study

  2015influential citation
• Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

  2015cites this paper
• Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy

  2014cites this paper
• Optimal duration of anticoagulation

  2014cites this paper
• The extra-pulmonary effects of chronic obstructive pulmonary disease (COPD)

  2014cites this paper
• Is it time to try or to trial statins to prevent recurrent venous thromboembolism?

  2014cites this paper
• The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study

  2014cites this paper
• Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study

  2014cites this paper
• Diagnosis and treatment of acute pulmonary embolism

  2013cites this paper
• Anticoagulant effects of statins and their clinical implications

  2013cites this paper
• Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study

  2013cites this paper